Pc. Lee et al., PATIENT DOSIMETRY QUALITY ASSURANCE PROGRAM WITH A COMMERCIAL DIODE SYSTEM, International journal of radiation oncology, biology, physics, 29(5), 1994, pp. 1175-1182
Citations number
12
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To evaluate a commercial silicone diode dosimeter for a patie
nt dosimetry quality assurance program. Methods and Materials: The dio
de dosimeter was calibrated against an ion chamber and percentage dept
h dose, linearity, anisotropy, virtual source position, and held size
factor studies were performed. Correction factors for lack of full sca
tter medium in the diode entrance and exit dose measurements were acqu
ired. Dosimetry equations were proposed for calculation of dose delive
red at isocenter. Diode dose accuracy and reproducibility were tested
on phantom and on four patients. A patient dosimetry quality assurance
program based on diode measured dose was instituted and patient dose
data were collected. Results: Diode measured percentage depth dose and
field factors agreed to within 3% with those measured with an ion cha
mber. The diode exhibited less than 1.7% angular dose anisotropy and l
ess than 0.5% nonlinearity up to 4 Gy. Diode dose measurements in phan
tom showed that the calculated doses differed from the prescribed dose
by less than 1.5%; the diode exhibited a daily dose reproducibility o
f better than 0.2%. On four selected patients, the measured dose repro
ducibility was 1.5%; the average calculated doses were all within +/-
7% of the prescribed doses. For 33 of 40 patients treated with a 6 MV
beam, measured doses were within +/- 7% of the prescribed doses. For 5
8 of 63 patients treated with an 18 MV beam, measured doses were withi
n +/- 7% of the prescribed doses. For 11 out of 12 patients, a second
repeat measurements yielded doses within +/- 7% of the prescribed dose
s. Conclusions: The proposed diode-based patient dosimetry quality ass
urance program with dose tolerance at +/- 7% is simple and feasible. I
t is capable of detecting certain serious treatment errors such as inc
orrect daily dose greater than 7%, incorrect wedge use, incorrect phot
on energy and patient setup errors involving some incorrect source-to-
surface-distance vs. source-to-axis-distance treatments.